These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23660181)

  • 1. Parathyroidectomy and heart rate variability in patients with stage 5 CKD.
    Zhang J; Yu X; Sun B; Bai J; Wei Y; Zha X; Cui Y; Zeng M; Zhang J; Liu J; Mao H; Zhang B; Ren H; Ge Y; Xu X; Shen Z; Xing C; Cao K; Wang N
    Clin J Am Soc Nephrol; 2013 Aug; 8(8):1378-87. PubMed ID: 23660181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD.
    Zhang LN; Yang G; Cheng C; Shen C; Cui YY; Zhang J; Zhang JJ; Shen ZX; Zeng M; Ge YF; Sun B; Yu XB; Ouyang C; Zhang B; Mao HJ; Liu J; Xing CY; Zha XM; Wang NN
    Osteoporos Int; 2015 Jan; 26(1):395-405. PubMed ID: 25224292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients.
    Chen H; Ren W; Gao Z; Zeng M; Tang S; Xu F; Huang Y; Zhang L; Cui Y; Yang G; Qian H; Zhou W; Ouyang C; Gao X; Zhang J; Xiao Y; Zhao B; Wang J; Bian A; Li F; Wan H; Gao W; Wang X; Xing C; Zha X; Wang N
    Ren Fail; 2021 Dec; 43(1):890-899. PubMed ID: 34044733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H; Cui Y; Xing C; Purrunsing Y; Zha X; Shen C; Zeng M; Yang G; Yu X; Zhang L; Jiang Y; Shen Z; Ma H; Yin C; Li Y; Wang N
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroidectomy Increases Heart Rate Variability and Leptin Levels in Patients with Stage 5 Chronic Kidney Disease.
    Jiang Y; Shen Z; Zhang J; Xing C; Zha X; Shen C; Zeng M; Yang G; Mao H; Zhang B; Yu X; Sun B; Ouyang C; Ge Y; Zhang L; Cheng C; Zhang J; Yin C; Chen H; Wang N
    Am J Nephrol; 2016; 44(3):245-54. PubMed ID: 27598394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients.
    Iwamoto N; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Nishimura M; Takatani T; Okamoto Y; Nakanouchi T; Koyama M; Adachi N; Ninomiya K; Mabuchi H; Iseki K
    Clin Exp Nephrol; 2016 Oct; 20(5):808-814. PubMed ID: 26677857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of parathyroid hormone levels and mineral parameters with heart rate variability in patients with end-stage renal disease.
    Zhang L; Yang S; Chen J; Ma J; Ren Y
    Int Urol Nephrol; 2017 Jun; 49(6):1079-1085. PubMed ID: 28243964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative Parathyroid Hormone Assay Remains Predictive of Cure in Renal Impairment in Patients with Single Parathyroid Adenomas.
    Egan RJ; Iliff H; Stechman MJ; Scott-Coombes DM
    World J Surg; 2018 Sep; 42(9):2835-2839. PubMed ID: 29497805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical analysis of the intraoperative parathyroid hormone decrease during parathyroidectomy for secondary and tertiary hyperparathyroidism.
    Silveira AA; Brescia MDG; do Nascimento CP; Arap SS; Montenegro FLM
    Surgery; 2020 Dec; 168(6):1079-1085. PubMed ID: 32811697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.
    Chen L; Wang K; Yu S; Lai L; Zhang X; Yuan J; Duan W
    Ren Fail; 2016 Aug; 38(7):1050-8. PubMed ID: 27198474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Increased Serum Leptin with Ameliorated Anemia and Malnutrition in Stage 5 Chronic Kidney Disease Patients after Parathyroidectomy.
    Jiang Y; Zhang J; Yuan Y; Zha X; Xing C; Shen C; Shen Z; Qin C; Zeng M; Yang G; Mao H; Zhang B; Yu X; Sun B; Ouyang C; Xu X; Ge Y; Wang J; Zhang L; Cheng C; Yin C; Zhang J; Chen H; Ma H; Wang N
    Sci Rep; 2016 Jun; 6():27918. PubMed ID: 27307101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid subcutaneous pre-sternal transplantation after parathyroidectomy for renal hyperparathyroidism. Long-term graft function.
    Echenique-Elizondo M; Amondarain JA; Vidaur F; Olalla C; Aribe F; Garrido A; Molina J; Rodrigo MT
    World J Surg; 2007 Jul; 31(7):1403-9. PubMed ID: 17516108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-mediated parathyroid hormone suppression test in uraemic secondary hyperparathyroidism.
    Xiang T; Wang Y; Lan T; Zhou L
    Nephrology (Carlton); 2021 Feb; 26(2):164-169. PubMed ID: 33058364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful parathyroidectomy guided by intraoperative parathyroid hormone monitoring for primary hyperparathyroidism is preserved in mild and moderate renal insufficiency.
    Marcadis AR; Teo R; Ouyang W; Farrá JC; Lew JI
    Surgery; 2018 Mar; 163(3):633-637. PubMed ID: 29273178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
    Lu KC; Ma WY; Yu JC; Wu CC; Chu P
    Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
    Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
    Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
    Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL
    J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism.
    Lin HC; Chen CL; Lin HS; Chou KJ; Fang HC; Liu SI; Hsu CY; Huang WC; Huang CW; Huang CK; Chang TY; Chang YT; Lee PT
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):508-15. PubMed ID: 24102421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.